Trial intelligence / Profile preview

TXA in Moderate and Severe TBI

NCT02645552Phase 3Unknown

Sponsor
Renji Hospital
Start
Jan 2016
Primary completion
Dec 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of tranexamic acid in traumatic brain injury (TBI), sponsored by Renji Hospital. Status: unknown.

02

Drugs

tranexamic acid
03

Conditions

traumatic brain injury (TBI)

Beyond the preview

Go deeper on NCT02645552.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02645552.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call